Lee Gary K. 4
4 · Lyell Immunopharma, Inc. · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Lee Gary K.
Chief Scientific Officer
Transactions
- Award
Option (right to buy)
2022-02-11+800,000→ 800,000 totalExercise: $6.04Exp: 2032-02-10→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]1/4 of the option shares shall vest on January 31, 2023, with the remaining option shares to vest in equal monthly installments over the following thirty-six months.